G00033MO

Summary
GlyTouCan ID
G00033MO
IUPAC Condensed
Gal(b1-3)[GlcNAc(b1-6)]GalNAc(a1-
Motifs
O-Glycan core 2
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
586.22
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
2452 2453 3486 3487 13751 16601 23753 30426 30851 33633 34767 35109 35110 36265 38265 38269 38650 42743 46429 47878
3D Structures
GlycoShape
G00033MO
Displaying 1 entry
Archetype α β
G00034MO
G00033MO
G24720OO
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B3GALNT2 UDP-GalNAc
G00033MO
Ser/Thr
G01707KB
Ser/Thr
GCNT1 UDP-GlcNAc
G00031MO
Ser/Thr (core 2)
G00033MO
Ser/Thr (core 2)
GCNT3 UDP-GlcNAc
G00031MO
Ser/Thr
G00033MO
Ser/Thr
GCNT4 UDP-GlcNAc
G00031MO
Ser/Thr
G00033MO
Ser/Thr
Displaying entries 1 - 5 of 22 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
ST3GAL1 CMP-Neu5Ac
G00033MO
O-glycan Synthesis
G85608AG
O-glycan Synthesis
FUT2 GDP-Fuc
G00033MO
O-glycan Synthesis
G32426JY
O-glycan Synthesis
B4GALT4 UDP-Gal
G00033MO
pNP
G64973KT
pNP
B4GALT1 UDP-Gal
G00033MO
O-glycan Synthesis
G64973KT
O-glycan Synthesis
B3GALNT2 UDP-GalNAc
G00033MO
(core2)-pNP
G01707KB
(core2)-pNP
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
GAL3ST3 PAPS
G00033MO
octyl
B3GNT7 UDP-GlcNAc
G00033MO
core 2-pNp
B3GNT8 UDP-GlcNAc
G00033MO
core 2-pNp
B3GNT6 UDP-GlcNAc
G00033MO
[alpha]-pNP(core 2)
KEGG BRITE Database
Sequence Descriptors
GlycoCT
RES
1b:a-dgal-HEX-1:5
2s:n-acetyl
3b:b-dgal-HEX-1:5
4b:b-dglc-HEX-1:5
5s:n-acetyl
LIN
1:1d(2+1)2n
2:1o(3+1)3d
3:1o(6+1)4d
4:4d(2+1)5n
WURCS
WURCS=2.0/3,3,2/[a2112h-1a_1-5_2*NCC/3=O][a2112h-1b_1-5][a2122h-1b_1-5_2*NCC/3=O]/1-2-3/a3-b1_a6-c1
Literature
Displaying entries 21 - 30 of 42 in total
PubMed ID Title First Author Publication Date Source
10753916 Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 beta1, 6-n-acetylglucosaminyltransferase Schwientek T 2000 Apr 14
  • PubChem
9915862 Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches Yeh JC 1999 Jan 29
  • PubChem
9988682 Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4 Schwientek T 1999 Feb 19
  • PubChem
10430883 Expression cloning of a human alpha1, 4-N-acetylglucosaminyltransferase that forms GlcNAcalpha1-->4Galbeta-->R, a glycan specifically expressed in the gastric gland mucous cell-type mucin Nakayama J 1999 Aug 03
  • PubChem
9530955 Purification and characterization of the MUC1 mucin-type glycoprotein, epitectin, from human urine: structures of the major oligosaccharide alditols Bhavanandan VP 1998 Jan
  • GlyGen
  • PubChem
9857011 Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1,4-galactosyltransferase IV and beta-1,3-n-acetylglucosaminyltransferase Ujita M 1998 Dec 25
  • PubChem
1329093 Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Bierhuizen MF 1992 Oct 01
  • PubChem
1627559 The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins Klein A 1992 Jul 7
  • GlyGen
1488058 Quantitation and structures of oligosaccharide chains in human trachea mucin glycoproteins Sangadala S 1992 Dec 02
  • GlyGen
3345749 Primary structure of neutral oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, determined by combination of 500-MHz 1H-NMR spectroscopy and quantitative sugar analysis. 1. Structure of 16 oligosaccharides having the Gal beta(1----3)GalNAc-ol core (type 1) or the Gal beta(1----3)[GlcNAc beta(1----6)]GalNac-ol core (type 2) Klein A 1988 Feb 1
  • GlyGen
PubAnnotation
Displaying entries 1 - 5 of 10 in total
Title Authors Source Publication Date PubMed ID
Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.
  • Müller S
  • Hanisch FG
J Biol Chem 2002 Jul 19 12000758
Specificities of N-acetylglucosamine-6-O-sulfotransferases in relation to L-selectin ligand synthesis and tumor-associated enzyme expression.
  • Uchimura K
  • El-Fasakhany FM
  • Hori M
  • Hemmerich S
  • Blink SE
  • Kansas GS
  • Kanamori A
  • Kumamoto K
  • Kannagi R
  • Muramatsu T
J Biol Chem 2002 Feb 8 11726653
The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
  • Dalziel M
  • Whitehouse C
  • McFarlane I
  • Brockhausen I
  • Gschmeissner S
  • Schwientek T
  • Clausen H
  • Burchell JM
  • Taylor-Papadimitriou J
J Biol Chem 2001 Apr 6 11118434
MUC1 and cancer.
  • Taylor-Papadimitriou J
  • Burchell J
  • Miles DW
  • Dalziel M
Biochim Biophys Acta 1999 Oct 8 10571020
An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
  • Burchell J
  • Poulsom R
  • Hanby A
  • Whitehouse C
  • Cooper L
  • Clausen H
  • Miles D
  • Taylor-Papadimitriou J
Glycobiology 1999 Dec 10561455

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025